Autoliv Inc (NYSE: ALV) shares are down Friday premarket following its mixed bag of first-quarter results amid a challenging operating environment, especially in Europe.
AIM ImmunoTech Inc. (NYSE:AMERICAN) ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune
Gainers
Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.